Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019

被引:7
作者
Castilla, Jesus [1 ,2 ]
Eugenia Portillo, Maria [3 ]
Casado, Itziar [1 ,2 ]
Pozo, Francisco [2 ,4 ]
Navascues, Ana [3 ]
Adelantado, Marta [3 ]
Gomez Ibanez, Carlos [1 ]
Ezpeleta, Carmen [3 ]
Martinez-Baz, Ivan [1 ,2 ]
机构
[1] Inst Salud Publ Navarra IdiSNA, Pamplona, Spain
[2] CIBERESP, Madrid, Spain
[3] Complejo Hosp Navarra IdiSNA, Pamplona, Spain
[4] Inst Salud Carlos III, WHO Natl Influenza Ctr Madrid, Ctr Nacl Microbiol, Majadahonda, Spain
关键词
Influenza; Influenza vaccine; Influenza-like illness; Case-control study; Vaccine effectiveness; Repeated vaccination; VACCINE EFFECTIVENESS; SEASON PROTECTION; UNITED-STATES; VIRUS; CHILDREN; HEMAGGLUTININ; A(H3N2); ILLNESS; CANADA;
D O I
10.1016/j.vaccine.2020.01.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The population targeted for influenza vaccination can be repeatedly vaccinated over successive seasons, and vaccines received in previous seasons may retain preventive effect. This study aims to estimate the effectiveness of inactivated influenza vaccines received in the current and prior seasons in the 2018-2019 season. Methods: Influenza-like illness patients attended by sentinel general practitioners or admitted to hospitals in Navarre, Spain, were tested for influenza. Vaccination status in the current and three prior seasons was obtained from the vaccination registry. The test-negative design was used to estimate the vaccine effectiveness. Results: A total of 381 influenza A(H1N1)pdm09 cases, 341 A(H3N2) cases and 1222 controls were analysed. As compared to individuals unvaccinated in the current and three prior seasons, the influenza vaccine effectiveness against A(H1N1)pdm09 was 57% (95% confidence interval ICI]: 40%, 70%) for current season vaccination regardless of prior doses and 48% (95%Cl: 14%, 68%) for vaccination in prior seasons but not in the current season. These estimates were 12% (95%CI: -23%, 37%) and 27% (95%CI: -22%, 56%), respectively, against influenza A(H3N2). Individuals vaccinated with the two A(H1N1)pdm09 strains in influenza vaccines since 2009, A/Michigan/45/2015 and A/California/07/2009, had higher protection (68%; 95%CI: 53%, 77%) than those vaccinated with A/Michigan/45/2015 only (29%, p = 0.020) or with A/California/07/2009 only (34%, p = 0.005). Conclusion: These results suggest moderate effectiveness of influenza vaccination against A(H1N1) pdm09 and low effectiveness against A(H3N2) influenza in the 2018-2019 season. Vaccination in prior seasons maintained a notable protective effect. Strains included in previous vaccines were as effective as the current vaccine strain, and both added their effects against influenza A(H1N1)pdm09. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1925 / 1932
页数:8
相关论文
共 50 条
  • [41] Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons
    Boikos, Constantina
    Fischer, Lauren
    O'Brien, Dan
    Vasey, Joe
    Sylvester, Gregg C.
    Mansi, James A.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) : 816 - 823
  • [42] A Retrospective Analysis of Gender-Based Difference in Adherence to Influenza Vaccination during the 2018-2019 Season
    Applewhite, Andres
    Stancampiano, Fernando F.
    Harris, Dana M.
    Manaois, Alyssa
    Dimuna, John
    Glenn, Jada
    Heckman, Michael G.
    Brushaber, Danielle E.
    Sher, Taimur
    Valery, Jose Raul
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
  • [43] Distinct but connected avian influenza virus activities in wetlands and live poultry markets in Bangladesh, 2018-2019
    Turner, Jasmine C. M.
    Barman, Subrata
    Feeroz, Mohammed M.
    Hasan, Md Kamrul
    Akhtar, Sharmin
    Walker, David
    Jeevan, Trushar
    Mukherjee, Nabanita
    El-Shesheny, Rabeh
    Seiler, Patrick
    Franks, John
    McKenzie, Pamela
    Kercher, Lisa
    Webster, Robert G.
    Webby, Richard J.
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (04) : E605 - E620
  • [44] CLINICAL AND LABORATORY CHARACTERISTICS OF INFLUENZA INFECTION IN HOSPITALIZED ADULT PATIENTS DURING THE 2018-2019 EPIDEMIC SEASON
    Voloshchuk, L. V.
    Go, A. A.
    Pisareva, M. M.
    Guzhov, D. A.
    Bichurina, M. A.
    Petrova, P. A.
    INFEKTSIYA I IMMUNITET, 2021, 11 (01): : 191 - 196
  • [45] Molecular analysis reveals a distinct subgenogroup of porcine epidemic diarrhea virus in northern Vietnam in 2018-2019
    Bui Thi Thuy Duong
    Pham Thi Phuong Thao
    Nguyen Thi Hoa
    Ha Thi Thu
    Man Hong Phuoc
    Thanh Hoa Le
    Dong Van Quyen
    ARCHIVES OF VIROLOGY, 2022, 167 (11) : 2337 - 2346
  • [46] Influenza vaccination coverage of professionals working in nursing homes in France and related determinants, 2018-2019 season: a cross-sectional survey
    Vaux, Sophie
    Fonteneau, Laure
    Venier, Anne-Gaelle
    Gautier, Arnaud
    Altrach, Sophan Soing
    Parneix, Pierre
    Levy-Bruhl, Daniel
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [47] Comparative Analysis of Influenza Epidemiology Before and After the COVID-19 Pandemic in Argentina (2018-2019 vs. 2022-2023)
    Gentile, Angela
    Juarez, Maria del Valle
    Ensinck, Gabriela
    Lopez, Oscar
    Melonari, Pablo
    Fernandez, Tatiana
    Gioiosa, Andres
    Lazarte, Gustavo
    Lobertti, Silvina
    Lucion, Maria Florencia
    Pejito, Natalia
    Racana, Camila
    Lopez, Leandro
    Gregorio, Gabriela
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2025, 19 (02)
  • [48] Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain)
    Acosta, Lesly
    Soldevila, Nuria
    Torner, Nuria
    Martinez, Ana
    Ayneto, Xavier
    Rius, Cristina
    Jane, Mireia
    Dominguez, Angela
    VIRUSES-BASEL, 2021, 13 (08):
  • [49] Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States
    Boikos, Constantina
    Fischer, Lauren
    O'Brien, Dan
    Vasey, Joe
    Sylvester, Gregg C.
    Mansi, James A.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E692 - E698
  • [50] Reply letter to "Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design"
    Hadigal, Sanjay
    Colombo, Laura
    Haughie, Scott
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)